Patents by Inventor Rene Roscher

Rene Roscher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR TREATING SARCOIDOSIS-ASSOCIATED PULMONARY HYPERTENSION
    Publication number: 20220331313
    Abstract: The present disclosure provides methods for treating sarcoidosis-associated pulmonary hypertension, comprising administering to a patient in need thereof, a therapeutically effective amount of selexipag, wherein the patient is diagnosed with sarcoidosis-associated pulmonary hypertension.
    Type: Application
    Filed: May 6, 2020
    Publication date: October 20, 2022
    Inventors: Ralph T. PREISS, Tatiana REMENOVA, Irina KONOURINA, Thomas PFISTER, René ROSCHER, Aline FREY, Natalia Catalina YANNOULIS ARCEDA, Rainer ZIMMERMANN, Keith John MORRISON, Shirin BRUDERER
  • Ciclesonide and glycopyrronium combination
    Publication number: 20070185067
    Abstract: The invention relates to pharmaceutical formulations containing combinations of ciclesonide and a pharmaceutically acceptable salt of glycopyrronium and the use of such pharmaceutical compositions in medicine, in particular in the prophylaxis and treatment of respiratory disease.
    Type: Application
    Filed: February 25, 2005
    Publication date: August 9, 2007
    Applicant: Altana Pharma AG
    Inventors: Rene Roscher, Christoph Karl
  • Roflumilast and glycopyrronium combination
    Publication number: 20070167496
    Abstract: The invention relates to pharmaceutical formulations containing combinations of roflumilast and a pharmaceutically acceptable salt of glycopyrronium and the use of such pharmaceutical compositions in medicine, in particular in the prophylaxis and treatment of respiratory disease.
    Type: Application
    Filed: February 25, 2005
    Publication date: July 19, 2007
    Applicant: Attana Pharma AG
    Inventors: Christoph Karl, Rene Roscher
  • Pharmaceutical formulation containing an LTB4 antagonist
    Publication number: 20030119901
    Abstract: The invention relates to a new pharmaceutical formulation containing an LTB4 antagonist of formula I 1
    Type: Application
    Filed: July 10, 2002
    Publication date: June 26, 2003
    Applicant: Boehringer Ingelheim Pharma KG
    Inventors: Robert Becker, Thomas Bock, Siglinde Moll, Rene Roscher, Ulrich Roth, Achim Sauer, Karl Weber